Ikeda Satoshi, Arita Machiko, Misaki Kenta, Kashiwagi Yumiko, Ito Yuhei, Yamada Hirotaka, Hotta Machiko, Nishiyama Akihiro, Ito Akihiro, Noyama Maki, Koyama Takashi, Notohara Kenji, Ishida Tadashi
Department of Respiratory Medicine, Kurashiki Central Hospital, Miwa 1-1-1, Kurashiki, 710-8602, Japan.
Department of Endocrinology and Rheumatology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
BMC Pulm Med. 2015 Jul 30;15:78. doi: 10.1186/s12890-015-0068-1.
The clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA) positive granulomatosis with polyangiitis (GPA) remain unclear, as does the difference between MPO-ANCA positive GPA and proteinase 3 (PR3)-ANCA positive GPA, especially with regard to the details of respiratory tract involvement. We investigated the differences in clinical, radiological, and histopathological features between PR3-ANCA positive GPA and MPO-ANCA positive GPA.
We retrospectively reviewed 16 patients who were newly diagnosed with GPA between December 2000 and July 2014. One patient, who was positive for both PR3-ANCA and MPO-ANCA, was excluded. Our review was based on the European Medicine Agency (EMA) algorithm.
Fifty-six percent of GPA patients were positive for PR3-ANCA, 38 % for MPO-ANCA, and the remaining 6 % for both. The MPO-ANCA positive group included a greater number of females (67 %). There were no statistically significant differences in laboratory data, symptoms and signs, Birmingham Vasculitis Activity Score, or CT findings between the two groups. As for upper respiratory tract involvement, the most common manifestation was paranasal sinusitis, whereas lung nodules were most common as the lower respiratory tract involvement in both groups. Although the combination therapy with prednisone and cyclophosphamide was the most common initial treatment in both groups, the relapse rate in MPO-ANCA positive cases was lower than that of PR3-ANCA positive cases (17 % and 56 %, respectively).
A high prevalence of MPO-ANCA positive GPA was noted. No significant differences in clinico-radiological findings were observed except for the prevalence of relapse between the PR3-ANCA positive cases and MPO-ANCA positive cases, suggesting that the type of ANCA may be of little help in the diagnosis of GPA. Examination for granulomatous findings in the respiratory tract is important, even in MPO-ANCA positive cases. There is a need to accumulate more cases and conduct a further investigation in the future.
髓过氧化物酶抗中性粒细胞胞浆抗体(MPO-ANCA)阳性的肉芽肿性多血管炎(GPA)的临床特征仍不清楚,MPO-ANCA阳性的GPA与蛋白酶3(PR3)-ANCA阳性的GPA之间的差异也不明确,尤其是在呼吸道受累细节方面。我们研究了PR3-ANCA阳性GPA和MPO-ANCA阳性GPA在临床、放射学和组织病理学特征上的差异。
我们回顾性分析了2000年12月至2014年7月期间新诊断为GPA的16例患者。排除1例PR3-ANCA和MPO-ANCA均阳性的患者。我们的回顾基于欧洲药品管理局(EMA)的算法。
GPA患者中56%为PR3-ANCA阳性,38%为MPO-ANCA阳性,其余6%两者均阳性。MPO-ANCA阳性组女性比例更高(67%)。两组之间在实验室数据、症状和体征、伯明翰血管炎活动评分或CT表现方面无统计学显著差异。至于上呼吸道受累,最常见的表现是鼻窦炎,而两组下呼吸道受累最常见的是肺结节。虽然泼尼松和环磷酰胺联合治疗是两组最常见的初始治疗方法,但MPO-ANCA阳性病例的复发率低于PR3-ANCA阳性病例(分别为17%和56%)。
注意到MPO-ANCA阳性GPA的患病率较高。除了PR3-ANCA阳性病例和MPO-ANCA阳性病例之间的复发率外,临床放射学表现未观察到显著差异,这表明ANCA类型对GPA的诊断可能帮助不大。即使在MPO-ANCA阳性病例中,检查呼吸道的肉芽肿表现也很重要。未来需要积累更多病例并进行进一步研究。